Historique
Bulletin de Périodique
Journal of Substance Abuse Treatment , Vol.41, n°3 - October 2011
Paru le :
10/10/2011
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Childhood sexual abuse and substance abuse treatment utilization among substance-dependent incarcerated women. Peltan J.R., Cellucci T., p. 215-224.
• Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder. Suter M., Strik W., Moggi F., p. 225-232.
• Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems. Orwat J., Saitz R., Tompkins C.P., Cheng D.M., Dentato M.P., Samet J.H., p. 233-242.
• If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. Humphreys K., Wagner T.H., Gage M., p. 243-251.
• Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Cousins G., Teljeur C., Motterlini N., McCowan C., Dimitrov B.D., Fahey T., p. 252-260.
• Who uses online interventions for problem drinkers? Cunningham J.A., Wild T.C., Humphreys K., p. 261-264.
• Drug assertiveness and sexual risk-taking behavior in a sample of HIV-positive, methamphetamine-using men who have sex with men. Semple S.J., Strathdee S.A., Zians J., McQuaid J.R., Patterson T.L., p. 265-272.
• Mortality rate among crack/cocaine-dependent patients: A 12-year prospective cohort study conducted in Brazil. Dias A.C., Araujo M.R., Dunn J., Sesso R.C., de Castro V., Laranjeira R., p. 273-278.
• Determining the efficacy of auricular acupuncture for reducing anxiety in patients withdrawing from psychoactive drugs. Black S., Carey E., Webber A., Neish N., Gilbert R., p. 279-287.
• Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts. Finigan M.W., Perkins T., Zold-Kilbourn P., Parks J., Stringer M., p. 288-293.
• Factors that influence trajectories of change in frequency of substance use and quality of life among adolescents receiving a brief intervention. Becker S.J., Curry J.F., Yang C.M., p. 294-304.
• Comparative utility of a single-item versus multiple-item measure of self-efficacy in predicting relapse among young adults. Hoeppner B.B., Kelly J.F., Urbanoski K.A., Slaymaker V., p. 305-312.
• Does clinician continuity over two brief motivational sessions improve outcomes in college students? Short E.E., Fernandez A., Borsari B., Hustad J.T.P., Wood M., p. 313-320.
• Efficacy of continuing medical education to reduce the risk of buprenorphine diversion. Lofwall M.R., Wunsch M.J., Nuzzo P.A., Walsh S.L., p. 321-329.
• Childhood sexual abuse and substance abuse treatment utilization among substance-dependent incarcerated women. Peltan J.R., Cellucci T., p. 215-224.
• Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder. Suter M., Strik W., Moggi F., p. 225-232.
• Substance abuse treatment utilization among adults living with HIV/AIDS and alcohol or drug problems. Orwat J., Saitz R., Tompkins C.P., Cheng D.M., Dentato M.P., Samet J.H., p. 233-242.
• If substance use disorder treatment more than offsets its costs, why don't more medical centers want to provide it? A budget impact analysis in the Veterans Health Administration. Humphreys K., Wagner T.H., Gage M., p. 243-251.
• Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study. Cousins G., Teljeur C., Motterlini N., McCowan C., Dimitrov B.D., Fahey T., p. 252-260.
• Who uses online interventions for problem drinkers? Cunningham J.A., Wild T.C., Humphreys K., p. 261-264.
• Drug assertiveness and sexual risk-taking behavior in a sample of HIV-positive, methamphetamine-using men who have sex with men. Semple S.J., Strathdee S.A., Zians J., McQuaid J.R., Patterson T.L., p. 265-272.
• Mortality rate among crack/cocaine-dependent patients: A 12-year prospective cohort study conducted in Brazil. Dias A.C., Araujo M.R., Dunn J., Sesso R.C., de Castro V., Laranjeira R., p. 273-278.
• Determining the efficacy of auricular acupuncture for reducing anxiety in patients withdrawing from psychoactive drugs. Black S., Carey E., Webber A., Neish N., Gilbert R., p. 279-287.
• Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts. Finigan M.W., Perkins T., Zold-Kilbourn P., Parks J., Stringer M., p. 288-293.
• Factors that influence trajectories of change in frequency of substance use and quality of life among adolescents receiving a brief intervention. Becker S.J., Curry J.F., Yang C.M., p. 294-304.
• Comparative utility of a single-item versus multiple-item measure of self-efficacy in predicting relapse among young adults. Hoeppner B.B., Kelly J.F., Urbanoski K.A., Slaymaker V., p. 305-312.
• Does clinician continuity over two brief motivational sessions improve outcomes in college students? Short E.E., Fernandez A., Borsari B., Hustad J.T.P., Wood M., p. 313-320.
• Efficacy of continuing medical education to reduce the risk of buprenorphine diversion. Lofwall M.R., Wunsch M.J., Nuzzo P.A., Walsh S.L., p. 321-329.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
G. COUSINS ;
C. TELJEUR ;
N. MOTTERLINI ;
C. McCOWAN ;
B. D. DIMITROV ;
T. FAHEY
|
2011
Dans Journal of Substance Abuse Treatment (Vol.41, n°3, October 2011) Article : Périodique
Dans Journal of Substance Abuse Treatment (Vol.41, n°3, October 2011) Article : Périodique
This study aims to identify periods of elevated risk of drug-related mortality during methadone maintenance treatment (MMT) in primary care using a cohort of 3,162 Scottish drug users between January 1993 and February 2004. Deaths occurring duri[...]
M. R. LOFWALL ;
M. J. WUNSCH ;
P. A. NUZZO ;
S. L. WALSH
|
2011
Dans Journal of Substance Abuse Treatment (Vol.41, n°3, October 2011) Article : Périodique
Dans Journal of Substance Abuse Treatment (Vol.41, n°3, October 2011) Article : Périodique
As office-based opioid dependence treatment (OBOT) has grown in the United States, postmarketing surveillance data reveal increased reports of buprenorphine misuse and diversion, it is important that doctors understand buprenorphine clinical pha[...]